Ostatní
Návod 
CVS Health Corporation
CVS
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
98.5B
Obrat
402B
Zisk
2B
Aktiva
255B
Dluh
82B
ROE
0%
ROA
0%
PE
52
PS
0
Cena 1R
52-85
⌀ Cena
71.56
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
11-02-2026
Poslední dividenda
22-01-2026
Profil
CVS Health Corporation poskytuje zdravotnické služby ve Spojených státech. Segment zdravotních dávek společnosti nabízí tradiční, dobrovolné a spotřebitelsky orientované produkty zdravotního pojištění a související služby. Slouží skupinám zaměstnavatelů, jednotlivcům, vysokoškolským studentům, zaměstnancům na částečný úvazek a na hodinu, zdravotnickým plánům, poskytovatelům zdravotní péče, vládním jednotkám, vládou financovaným plánům, pracovním skupinám a emigrantům. Segment lékárenských služeb nabízí řešení pro řízení lékárenských výhod, včetně návrhu a podávání plánů, řízení formulary, řízení sítě lékáren v maloobchodě, lékárny zásilkového prodeje, specializované lékárny a infuze, klinických a nemocí a služeb řízení léčebných výdajů. Slouží zaměstnavatelům, pojišťovnám, odborům, vládním skupinám zaměstnanců, zdravotním plánům, lékovým plánům na předpis, plánům spravované péče programu Medicaid, plánům nabízeným v oblasti veřejného zdravotního pojištění a soukromým výměnám zdravotního pojištění, dalším sponzorům plánů zdravotních dávek a jednotlivcům. Tento segment provozuje maloobchodní specializované lékárny a specializované zásilkové, zásilkové a smíšené lékárny, stejně jako pobočky pro infuzní a zábavní výživu. Segment maloobchodu/LTC společnosti prodává léky na předpis a volně prodejné léky, výrobky pro zdraví a krásu spotřebitelů a výrobky pro osobní péči a poskytuje služby zdravotní péče prostřednictvím svých lékařských klinik MinuteClinic. Tento segment také distribuuje léky na předpis a poskytuje související farmaceutické poradenství a další doplňkové služby pro pečovatelská zařízení a další pečovatelská zařízení. K 31. prosinci 2021 provozovala přibližně 9900 maloobchodních a 1200 minutových poboček kliniky, jakož i internetové lékárny, LTC lékárny a lékárny na místě. Společnost byla dříve známá jako CVS Caremark Corporation a v září 2014 změnila svůj název na CVS Health Corporation. Společnost CVS Health Corporation byla založena v roce 1963 a sídlí ve Woonsocketu na Rhode Islandu.
Sektor
Healthcare
Odvětví
Medical - Healthcare Plans
Počet zaměstnanců
219000
Založení
1996-11-20
Podobné společnosti
$ 848.98
- $ 3.01
$ 260.66
- $ 3.93
$ 305.00
- $ 12.78
$ 46.75
+ $ 0.12
$ 455.55
- $ 21.06
$ 46.93
+ $ 0.24
$ 415.16
+ $ 5.69
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliardách (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 402.1 | 402.1 | 372.8 | 357.8 | 322.5 | 292.1 | 268.7 | 256.8 | 194.6 | 184.8 | 177.5 | 153.3 | 139.4 | 126.8 | 123.1 | 107.1 | 96.4 | |
| Cost of Revenues | 346.7 | 346.7 | 321.4 | 303.3 | 268.2 | 240.1 | 219.7 | 211.2 | 163.0 | 156.2 | 148.7 | 126.8 | 114.0 | 103.0 | 100.6 | 86.5 | 76.2 | |
| Gross Profit | 55.4 | 55.4 | 51.4 | 54.4 | 54.3 | 52.0 | 49.0 | 45.5 | 31.5 | 28.5 | 28.9 | 26.5 | 25.4 | 23.8 | 22.5 | 20.6 | 20.3 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 105.7 | 102.9 | 98.9 | 94.6 | 97.7 | 95.4 | 91.2 | 88.4 | 93.8 | 89.8 | |
| Cost of Revenues | 92.1 | 89.1 | 85.3 | 80.2 | 84.8 | 82.9 | 77.9 | 75.9 | 79.9 | 76.2 | |
| Gross Profit | 13.6 | 13.8 | 13.6 | 14.4 | 12.9 | 12.6 | 13.4 | 12.6 | 13.9 | 13.6 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 14.2 | 14.1 | |
| Depreciation & Amortization | 4.6 | 4.6 | 4.6 | 4.4 | 4.2 | 6.5 | 4.6 | 4.5 | 2.7 | 2.5 | 2.5 | 2.1 | 1.9 | 1.9 | 1.8 | 1.6 | 1.5 | |
| Total Operating Expenses | 50.7 | 45.0 | 42.9 | 40.7 | 38.2 | 37.1 | 35.1 | 33.5 | 21.4 | 19.0 | 18.5 | 17.1 | 16.6 | 15.7 | 15.3 | 14.2 | 14.1 | |
| Operating Income | 4.7 | 10.4 | 8.5 | 13.7 | 16.3 | 13.2 | 13.9 | 12.0 | 4.0 | 9.5 | 10.3 | 9.5 | 8.8 | 8.0 | 7.2 | 6.3 | 6.2 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Depreciation & Amortization | 1.1 | 1.1 | 1.2 | 1.2 | 1.1 | 1.2 | 1.2 | 1.1 | 1.1 | 1.1 | ||
| Total Operating Expenses | 11.5 | 17.0 | 11.2 | 11.0 | 10.5 | 11.7 | 10.3 | 10.3 | 10.5 | 9.9 | ||
| Operating Income | 2.1 | -3.2 | 2.4 | 3.4 | 2.4 | 0.8 | 3.0 | 2.3 | 3.4 | 3.7 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 3.1 | 3.1 | 3.0 | 2.7 | 2.3 | 2.5 | 2.9 | 3.0 | 2.6 | 1.1 | 1.1 | 0.9 | 0.6 | 0.5 | 0.6 | 0.6 | 0.5 | |
| Other Expense | -2.5 | -8.2 | -2.4 | -2.6 | -10.6 | -2.8 | -4.1 | -3.0 | -6.1 | -0.2 | -0.6 | -0.8 | -0.5 | -0.5 | -0.3 | -0.6 | -0.5 | |
| IBT | 2.1 | 2.1 | 6.1 | 11.2 | 5.6 | 10.4 | 9.8 | 9.0 | 1.4 | 8.3 | 8.6 | 8.6 | 7.7 | 7.5 | 6.3 | 5.7 | 5.6 | |
| Income Tax Expense | 0.4 | 0.4 | 1.6 | 2.8 | 1.5 | 2.5 | 2.6 | 2.4 | 2.0 | 1.6 | 3.3 | 3.4 | 3.0 | 2.9 | 2.4 | 2.3 | 2.2 | |
| Net Income | 1.8 | 1.8 | 4.6 | 8.3 | 4.3 | 7.9 | 7.2 | 6.6 | -0.6 | 6.6 | 5.3 | 5.2 | 4.6 | 4.6 | 3.9 | 3.5 | 3.4 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Interest Expense | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | ||
| Other Expense | -0.8 | -0.3 | -0.7 | -0.8 | -0.2 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | ||
| IBT | 1.4 | -3.5 | 1.6 | 2.6 | 2.1 | 0.1 | 2.3 | 1.6 | 2.7 | 3.0 | ||
| Income Tax Expense | -1.6 | 0.5 | 0.6 | 0.8 | 0.5 | 0.0 | 0.6 | 0.5 | 0.7 | 0.8 | ||
| Net Income | 2.9 | -4.0 | 1.0 | 1.8 | 1.6 | 0.1 | 1.8 | 1.1 | 2.0 | 2.3 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $6.49 | $3.16 | $6.00 | $5.48 | $5.10 | $-0.57 | $6.47 | $4.93 | $4.66 | $3.98 | $3.77 | $3.05 | $2.59 | $2.51 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $6.47 | $3.14 | $5.95 | $5.46 | $5.08 | $-0.57 | $6.44 | $4.90 | $4.63 | $3.96 | $3.74 | $3.03 | $2.57 | $2.49 | |
| Shares Outstanding | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.0 | 1.0 | 1.1 | 1.1 | 1.2 | 1.2 | 1.3 | 1.3 | 1.4 | |
| Diluted Shares Outstanding | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.0 | 1.0 | 1.1 | 1.1 | 1.2 | 1.2 | 1.3 | 1.3 | 1.4 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.59 | $1.76 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.59 | $1.75 | ||
| Shares Outstanding | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | ||
| Diluted Shares Outstanding | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 12.6 | 8.6 | 8.2 | 12.9 | 9.4 | 7.9 | 5.7 | 4.1 | 1.7 | 3.4 | 2.5 | 2.5 | 4.1 | 1.4 | 1.4 | 1.4 | |
| Short Term Investments | 3.8 | 2.4 | 3.3 | 2.8 | 3.1 | 3.0 | 2.4 | 2.5 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 16.3 | 11.0 | 11.5 | 15.7 | 12.5 | 10.9 | 8.1 | 6.6 | 1.8 | 3.5 | 2.5 | 2.5 | 4.2 | 1.4 | 1.4 | 1.4 | |
| Accounts Receivable | 32.4 | 36.5 | 35.2 | 27.3 | 24.4 | 21.7 | 19.6 | 17.6 | 13.2 | 12.2 | 11.9 | 9.7 | 8.7 | 6.5 | 6.0 | 4.9 | |
| Inventory | 16.1 | 18.1 | 18.0 | 19.1 | 17.8 | 18.5 | 17.5 | 16.5 | 15.3 | 14.8 | 14.0 | 11.9 | 11.0 | 10.8 | 10.0 | 10.7 | |
| Other Current Assets | 5.2 | 3.1 | 3.2 | 2.7 | 5.3 | 5.3 | 5.1 | 4.6 | 0.9 | 0.7 | 0.7 | 0.9 | 0.5 | 0.6 | 0.6 | 0.1 | |
| Total Current Assets | 70.0 | 68.6 | 67.9 | 65.7 | 60.0 | 56.4 | 50.3 | 45.2 | 31.2 | 31.0 | 30.4 | 26.0 | 25.3 | 19.9 | 18.6 | 17.7 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 9.2 | 11.8 | 10.1 | 8.6 | 6.9 | 12.5 | 9.8 | 8.2 | 13.0 | 13.8 | |
| Short Term Investments | 2.1 | 2.4 | 2.6 | 2.4 | 2.8 | 3.8 | 3.3 | 3.3 | 3.1 | 3.1 | |
| Total Cash & ST Investments | 11.3 | 14.2 | 12.7 | 11.0 | 9.7 | 16.3 | 13.1 | 11.5 | 16.2 | 16.9 | |
| Accounts Receivable | 43.9 | 40.7 | 39.6 | 36.5 | 36.2 | 32.4 | 32.2 | 35.2 | 32.9 | 29.5 | |
| Inventory | 19.0 | 17.4 | 17.4 | 18.1 | 17.6 | 16.1 | 16.3 | 18.0 | 18.0 | 17.3 | |
| Other Current Assets | 3.0 | 3.3 | 3.5 | 3.1 | 3.8 | 5.2 | 5.8 | 3.2 | 3.1 | 4.0 | |
| Total Current Assets | 77.1 | 75.6 | 73.2 | 68.6 | 67.3 | 70.0 | 67.5 | 67.9 | 70.1 | 67.8 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 29.9 | 28.9 | 30.4 | 30.7 | 32.0 | 33.3 | 32.9 | 11.3 | 10.3 | 10.2 | 9.9 | 8.8 | 8.6 | 8.6 | 8.5 | 8.3 | |
| Goodwill | 91.3 | 91.3 | 91.3 | 78.2 | 79.1 | 79.6 | 79.7 | 78.7 | 38.5 | 38.2 | 38.1 | 28.1 | 26.5 | 26.4 | 26.5 | 25.7 | |
| Intangible Assets | 28.3 | 27.3 | 29.2 | 24.8 | 29.0 | 31.1 | 33.1 | 36.5 | 13.6 | 13.5 | 13.9 | 9.8 | 9.5 | 9.8 | 9.9 | 9.8 | |
| Long-Term Investments | 25.3 | 28.9 | 23.0 | 21.1 | 23.0 | 20.8 | 17.3 | 15.7 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 3.7 | 8.1 | 7.9 | 4.0 | 4.7 | 4.6 | 4.6 | 5.0 | 1.5 | 1.5 | 1.4 | 1.5 | 1.5 | 1.3 | 1.2 | 0.7 | |
| Total Long-Term Assets | 182.5 | 184.6 | 181.9 | 162.6 | 173.0 | 174.3 | 172.1 | 151.2 | 63.9 | 63.4 | 63.3 | 48.3 | 46.2 | 46.1 | 45.9 | 44.5 | |
| Total Assets | 252.5 | 253.2 | 249.7 | 228.3 | 233.0 | 230.7 | 222.4 | 196.5 | 95.1 | 94.5 | 93.7 | 74.3 | 71.5 | 65.9 | 64.5 | 62.2 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 28.1 | 28.3 | 28.6 | 28.9 | 29.0 | 29.9 | 30.1 | 30.4 | 30.6 | 30.7 | |
| Goodwill | 85.5 | 91.2 | 91.2 | 91.3 | 91.3 | 91.3 | 91.3 | 91.3 | 91.3 | 91.3 | |
| Intangible Assets | 26.0 | 26.2 | 26.6 | 27.3 | 27.8 | 28.3 | 28.8 | 29.2 | 29.6 | 30.1 | |
| Long-Term Investments | 31.8 | 30.1 | 28.9 | 28.9 | 28.9 | 25.0 | 24.1 | 23.0 | 21.7 | 22.1 | |
| Other Long-Term Assets | 6.9 | 6.9 | 7.2 | 8.1 | 8.1 | 8.0 | 8.1 | 7.9 | 8.0 | 8.1 | |
| Total Long-Term Assets | 178.2 | 182.7 | 182.4 | 184.6 | 185.1 | 182.5 | 182.3 | 181.9 | 181.2 | 182.3 | |
| Total Assets | 255.3 | 258.3 | 255.6 | 253.2 | 252.4 | 252.5 | 249.7 | 249.7 | 251.3 | 250.1 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 52.5 | 15.9 | 14.9 | 14.8 | 12.5 | 11.1 | 10.5 | 8.9 | 8.9 | 7.9 | 7.5 | 6.5 | 5.5 | 5.1 | 4.4 | 4.0 | |
| Short-Term Debt | 5.6 | 7.5 | 4.7 | 3.5 | 5.9 | 7.1 | 5.4 | 2.0 | 4.8 | 1.9 | 1.2 | 1.3 | 0.6 | 0.7 | 0.8 | 1.4 | |
| Other Current Liabilities | 23.1 | 61.2 | 59.6 | 47.6 | 5.6 | 5.8 | 4.8 | 4.9 | 17.0 | 16.4 | 14.5 | 11.2 | 9.3 | 8.0 | 6.8 | 5.6 | |
| Current Liabilities | 81.4 | 84.6 | 79.2 | 69.7 | 67.8 | 62.0 | 53.3 | 44.0 | 30.6 | 26.3 | 23.2 | 19.0 | 15.4 | 13.8 | 12.0 | 11.1 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 60.9 | 17.3 | 16.5 | 15.9 | 15.7 | 14.4 | 13.7 | 14.9 | 14.9 | 13.4 | |
| Short-Term Debt | 7.2 | 11.1 | 7.6 | 7.5 | 7.6 | 5.6 | 8.4 | 4.7 | 3.9 | 4.1 | |
| Other Current Liabilities | 24.5 | 65.8 | 64.8 | 61.2 | 61.3 | 61.3 | 61.2 | 59.6 | 62.8 | 61.7 | |
| Current Liabilities | 92.7 | 94.2 | 89.0 | 84.6 | 84.6 | 81.4 | 83.3 | 79.2 | 81.6 | 79.2 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 62.6 | 75.4 | 74.7 | 67.3 | 70.1 | 78.0 | 83.6 | 71.4 | 22.2 | 25.6 | 26.3 | 11.7 | 12.8 | 9.1 | 9.2 | 8.7 | |
| Capital Leases | 15.5 | 16.7 | 17.8 | 18.5 | 19.8 | 20.4 | 20.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 4.1 | 3.8 | 4.3 | 3.9 | 6.3 | 6.8 | 7.3 | 7.7 | 3.0 | 4.2 | 5.4 | 4.0 | 3.9 | 3.8 | 3.9 | 3.7 | |
| Total Liabilities | 177.4 | 177.5 | 173.1 | 157.0 | 157.6 | 161.0 | 158.3 | 137.9 | 57.4 | 57.6 | 56.5 | 36.3 | 33.6 | 28.2 | 26.5 | 24.4 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 74.5 | 71.6 | 73.6 | 75.4 | 75.1 | 78.2 | 73.4 | 74.7 | 76.2 | 78.0 | |
| Capital Leases | 15.9 | 16.2 | 16.5 | 16.7 | 17.2 | 15.5 | 17.6 | 17.8 | 18.2 | 18.3 | |
| Def. Tax Liability | 3.5 | 3.6 | 3.7 | 3.8 | 3.6 | 4.1 | 4.2 | 4.3 | 4.3 | 4.6 | |
| Total Liabilities | 182.2 | 180.8 | 178.5 | 177.5 | 177.3 | 177.4 | 175.6 | 173.1 | 176.8 | 177.1 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 49.0 | 48.2 | 47.4 | 46.5 | 46.0 | 45.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | 62.8 | 62.8 | 61.6 | 56.1 | 54.9 | 49.6 | 45.1 | 40.9 | 43.6 | 39.0 | 35.5 | 31.8 | 28.5 | 25.0 | 22.1 | 19.3 | |
| Comprehensive Income | -0.3 | -0.1 | -0.3 | -1.5 | 1.0 | 1.4 | 1.0 | 0.1 | -0.2 | -0.3 | -0.4 | -0.2 | -0.1 | -0.2 | -0.2 | -0.1 | |
| Total Common Equity | 74.9 | 75.6 | 76.5 | 71.0 | 75.1 | 69.4 | 63.9 | 58.2 | 37.7 | 36.8 | 37.2 | 38.0 | 37.9 | 37.7 | 38.1 | 37.7 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 50.2 | 0.0 | 49.8 | 49.7 | 49.5 | 49.4 | 49.2 | 49.0 | 48.8 | 48.6 | |
| Retained Earnings | 59.1 | 63.9 | 63.8 | 62.8 | 62.0 | 62.8 | 61.9 | 61.6 | 60.3 | 58.9 | |
| Comprehensive Income | 0.4 | 0.3 | 0.1 | -0.1 | 0.2 | -0.3 | -0.3 | -0.3 | -1.0 | -0.9 | |
| Total Common Equity | 72.9 | 77.4 | 76.9 | 75.6 | 74.9 | 74.9 | 74.0 | 76.5 | 74.3 | 72.7 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 83.8 | 82.9 | 79.4 | 70.7 | 76.0 | 85.0 | 89.0 | 73.4 | 27.0 | 27.5 | 27.5 | 13.0 | 13.4 | 9.8 | 10.0 | 10.1 | |
| Book Value | 75.1 | 75.7 | 76.6 | 71.3 | 75.4 | 69.7 | 64.2 | 58.5 | 37.7 | 36.8 | 37.2 | 38.0 | 37.9 | 37.7 | 38.1 | 37.7 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | |
| Book Value | 72.9 | 77.4 | 76.9 | 75.6 | 74.9 | 74.9 | 74.0 | 76.5 | 74.3 | 72.7 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 7.2 | 1.8 | 4.6 | 8.4 | 4.2 | 7.9 | 7.2 | 6.6 | -0.6 | 6.6 | 5.3 | 5.2 | 4.6 | 4.6 | 3.9 | 3.5 | 3.4 | |
| Depreciation & Amortization | 4.6 | 0.0 | 4.6 | 4.4 | 4.2 | 4.5 | 4.4 | 4.4 | 2.7 | 2.5 | 2.5 | 2.1 | 1.9 | 1.9 | 1.8 | 1.6 | 1.5 | |
| Stock-Based Compensation | 0.6 | 0.0 | 0.5 | 0.6 | 0.4 | 0.5 | 0.4 | 0.5 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | |
| Change Working Capital | -3.9 | -1.5 | 0.1 | 0.0 | 7.0 | 3.9 | 3.2 | 1.5 | -0.1 | -0.4 | 1.3 | 1.1 | 0.9 | -0.7 | 0.7 | 0.6 | -0.3 | |
| Change In Accounts Receivable | -2.7 | -3.5 | -1.3 | -6.3 | -3.0 | -2.7 | -1.5 | -2.2 | -1.1 | -0.9 | -0.2 | -1.6 | -0.7 | -2.2 | -0.4 | -0.7 | 0.5 | |
| Change In Accounts Payable | 4.3 | 3.9 | 2.3 | 3.6 | 4.3 | 2.9 | 2.8 | 3.6 | 2.5 | 1.7 | 2.2 | 2.8 | 1.7 | 1.0 | 1.1 | 1.1 | 0.0 | |
| Change In Inventories | 1.4 | -1.3 | -0.1 | 1.2 | -1.4 | 0.7 | -1.0 | -1.1 | -1.2 | -0.5 | -0.7 | -1.1 | -0.8 | 0.0 | -0.9 | 0.6 | -0.4 | |
| Other Non-cash Items | -0.4 | 10.3 | -0.2 | 0.8 | 2.4 | 1.9 | 1.2 | 0.5 | 6.5 | 0.4 | 0.6 | 0.0 | 0.5 | 0.0 | 0.3 | -0.1 | 0.0 | |
| Cash from Operations | 8.1 | 0.0 | 0.0 | 13.4 | 16.2 | 18.3 | 15.9 | 12.8 | 8.9 | 8.0 | 10.1 | 8.4 | 8.1 | 5.8 | 6.7 | 5.9 | 4.8 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 2.9 | -2.8 | 1.0 | 1.8 | 1.6 | 0.1 | 1.8 | 1.1 | 2.0 | 2.3 | |
| Depreciation & Amortization | 1.1 | -2.3 | 1.2 | 1.2 | 1.1 | 1.2 | 1.2 | 1.1 | 1.1 | 1.1 | |
| Stock-Based Compensation | 0.0 | -0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | |
| Change Working Capital | -1.0 | -1.6 | -0.3 | 1.4 | -0.4 | -2.4 | 0.2 | 2.7 | -6.0 | -0.7 | |
| Change In Accounts Receivable | 4.0 | -3.4 | -1.1 | -3.1 | -0.3 | -3.8 | -0.2 | 3.0 | -2.3 | -3.1 | |
| Change In Accounts Payable | -1.9 | 2.0 | 0.8 | 3.0 | 0.2 | 1.0 | 2.6 | -1.4 | 1.2 | 2.6 | |
| Change In Inventories | -0.3 | -1.7 | -0.1 | 0.7 | -0.5 | -1.6 | 0.3 | 1.7 | -0.1 | -0.5 | |
| Other Non-cash Items | -0.2 | 7.3 | 0.0 | 0.2 | -1.0 | 0.8 | 0.0 | 0.0 | 0.4 | 0.2 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.6 | 2.7 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -2.8 | -2.8 | -2.8 | -3.0 | -2.7 | -2.5 | -2.4 | -2.5 | -2.0 | -1.9 | -2.2 | -2.4 | -2.1 | -2.0 | -2.0 | -1.9 | -2.0 | |
| Acquisitions | -0.2 | -0.4 | -0.1 | -16.6 | -1.4 | -0.1 | 0.0 | -0.4 | -41.4 | -1.3 | -0.5 | -11.5 | -2.4 | -0.4 | -0.4 | -1.2 | -0.2 | |
| Investments | -11.3 | -15.0 | -15.2 | -9.0 | -7.7 | -10.0 | -9.6 | -7.5 | -0.7 | -0.1 | -0.1 | -0.3 | -0.2 | -0.2 | 0.0 | 0.0 | -0.5 | |
| Sales of Investment | 8.5 | 12.4 | 10.4 | 7.7 | 6.7 | 7.2 | 6.5 | 7.0 | 0.8 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.0 | 0.7 | 0.5 | |
| Other Investing Activities | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.3 | 0.3 | 0.4 | 0.5 | 0.7 | 0.6 | 0.0 | 0.5 | |
| Cash from Investing | -5.7 | 0.0 | 0.0 | -20.9 | -5.0 | -5.3 | -5.5 | -3.3 | -43.3 | -2.9 | -2.5 | -13.4 | -4.0 | -1.8 | -1.8 | -2.4 | -1.6 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.8 | -0.7 | -0.6 | -0.7 | -0.8 | -0.7 | -0.6 | -0.7 | -0.9 | -0.5 | |
| Acquisitions | 0.0 | 0.1 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | |
| Investments | -4.0 | -3.9 | -3.6 | -3.6 | -2.5 | -5.9 | -3.2 | -3.5 | -2.4 | -2.1 | |
| Sales of Investment | 2.7 | 2.8 | 3.3 | 3.5 | 2.7 | 3.2 | 2.3 | 2.2 | 2.2 | 1.9 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.2 | -0.8 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -6.9 | 0.0 | 0.0 | 7.9 | -4.2 | -10.3 | -15.6 | -9.1 | -6.1 | -0.6 | -5.9 | -3.6 | -3.1 | -0.7 | -1.8 | -1.7 | -2.1 | |
| Debt Issued | 8.6 | 82.9 | 3.5 | 16.6 | -1.1 | 1.2 | 11.7 | 24.6 | 52.5 | 0.1 | 6.0 | 18.1 | 2.7 | 4.3 | 1.6 | 1.6 | 12.2 | |
| Issuance of Common Stock | 0.4 | 0.0 | 0.0 | 0.0 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 5.6 | 15.1 | 2.6 | 4.5 | 2.1 | 1.9 | 1.3 | |
| Repurchase of Common Stock | -3.0 | 0.0 | -3.0 | -2.0 | -3.5 | 0.0 | 0.0 | 0.0 | 0.0 | -4.4 | -4.5 | -5.0 | -4.0 | -4.0 | -4.3 | -3.0 | -1.5 | |
| Dividends Paid | -3.3 | 0.0 | 0.0 | -3.1 | -2.9 | -2.6 | -2.6 | -2.6 | -2.0 | -2.0 | -1.8 | -1.6 | -1.3 | -1.1 | -0.8 | -0.7 | -0.5 | |
| Other Financing Activities | -0.3 | 0.0 | 0.0 | -0.1 | -0.4 | 1.5 | 10.1 | 3.8 | 44.9 | -0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Cash from Financing | -3.6 | 0.0 | 0.0 | 2.7 | -10.5 | -11.4 | -8.2 | -7.9 | 36.8 | -6.8 | -6.7 | 5.0 | -5.7 | -1.2 | -4.9 | -3.5 | -2.8 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | -1.9 | |
| Debt Issued | 81.8 | -1.0 | 1.5 | -1.7 | 0.2 | -1.1 | 2.0 | 2.4 | -0.5 | -0.1 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.8 | -0.8 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.0 | -2.7 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -1.3 | -0.2 | 0.4 | -4.8 | 0.6 | 1.6 | 2.2 | 1.7 | 2.4 | -1.7 | 0.9 | 0.0 | -1.6 | 2.7 | 0.0 | 0.0 | 0.3 | |
| Closing Cash Balance | 12.6 | 8.7 | 8.9 | 8.5 | 13.3 | 12.7 | 8.1 | 6.0 | 4.3 | 1.7 | 3.4 | 2.5 | 2.5 | 4.1 | 1.4 | 1.4 | 1.4 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -0.7 | -2.7 | 1.7 | 1.5 | 1.7 | -5.7 | 2.7 | 1.6 | -4.9 | -0.8 | |
| Closing Cash Balance | 8.5 | 9.4 | 12.0 | 10.3 | 8.9 | 7.1 | 12.8 | 10.1 | 8.5 | 13.4 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 5.3 | 7.8 | 6.3 | 10.4 | 13.5 | 15.7 | 13.4 | 10.4 | 6.8 | 6.1 | 7.8 | 6.0 | 6.0 | 3.8 | 4.6 | 4.0 | 2.8 | |
| Real Free Cash Flow | 4.7 | 7.8 | 5.8 | 9.8 | 13.0 | 15.3 | 13.0 | 9.9 | 6.5 | 5.9 | 7.6 | 5.8 | 5.8 | 3.7 | 4.5 | 3.8 | 2.6 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 2.6 | 0.1 | 1.3 | 3.8 | 1.1 | -1.4 | 2.5 | 4.2 | -3.5 | 2.2 | |
| Real Free Cash Flow | 2.6 | 0.2 | 1.2 | 3.7 | 1.0 | -1.5 | 2.3 | 4.1 | -3.7 | 2.0 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 51.6 | 14.1 | 51.6 |
| P/S | 0.2 | 0.5 | 0.9 |
| P/B | 1.2 | 1.8 | 21.2 |
| P/FCF | 11.9 | 16 | 152.6 |
| Market cap | $98.5 | $84.9 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 27.8 % | 0 % |
| Debt to Income | 4624 % | 51.7 % | 0 % |
| Debt to Free cash flow | 1065.7 % | 22 % | 0 % |
| Interest expense percentage | 66.9 % | 18.8 % | 0 % |
| Current ratio | 0.8 | 1.2 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 2.4 % | 9.7 % | 0 % |
| ROA | 0.7 % | 4 % | 0 % |
| CapEx to Revenue | 0.7 % | 1.2 % | 0 % |
| RaD to Revenue | 0 % | 0 % | 0 % |
| ROEM | 1,340,223.3 | 366680.6 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 13.8 % | 17 % | 0 % |
| Operating margin | 1.2 % | 4.9 % | 0 % |
| Net margin | 0.4 % | 2.6 % | 0 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 2.2 % | 0 % |
| Dividend payout percentage | 0 % | 24.2 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 1,277.0 mil | 1,234.5 mil |
| Employee count | 300.0 tis | 224.6 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
